Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes. Pediatric diabetes Buckingham, B., Sherr, J., Prestrelski, S. J., Conoscenti, V. 2022

Abstract

Prompt and reliable management of hypoglycemia in youth with diabetes is important to prevent serious medical complications.To determine efficacy, pharmacodynamics (PD), pharmacokinetics (PK), safety, and tolerability of a ready-to-use, liquid stable glucagon formulation administered subcutaneously via an autoinjector pen to youth with type 1 diabetes (T1D).After plasma glucose concentration was

View details for DOI 10.1111/pedi.13360

View details for PubMedID 35562186